マルチオミクスは,クローン病における腸内記憶CD4+T細胞の転写プログラムを発見した
Mitsuru Arase1,2, Mari Murakami1,2, Takako Kihara3
1Department of Microbiology and Immunology, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
The Journal of experimental medicine
|September 4, 2025
まとめ
クローン病における組織内定記憶T細胞 (TRM) は,RUNX2とBHLHE40によって調節される. これらの要因は疾患特有のT細胞特性を駆動し,その調節は病原性フェノタイプに影響を与え,治療標的を提供します.
科学分野:
- 免疫学
- 細胞生物学
- 胃腸内科
背景:
- 組織内記憶T細胞 (TRM) は,炎症部位における免疫記憶に不可欠です.
- 独特のCD4+TRMサブセットは,クローン病 (CD) の患者の炎症した腸内粘膜に関与しています.
研究 の 目的:
- クローン病の腸内粘膜におけるCD4+TRMサブセットの特徴を特定する.
- 疾患特有のCD4+TRMの重要な転写レギュレータを特定する.
主な方法:
- 多層単細胞分析:クロマチン,遺伝子,タンパク質のプロファイリング.
- 患者と健康なドナーから得られたCD4+T細胞の分析
- 転写因子 (RUNX2,BHLHE40) の機能の評価
主要な成果:
- RUNX2とBHLHE40をCDにおける病原性CD4+TRMの主要な調節体として特定した.
- RUNX2/ BHLHE40が細胞毒性,Tヘルパー1エフェクター活性,およびCD4+TRMにおける組織保持を誘導することが示された.
- RUNX2/BHLHE40をダウン調節することで,患者由来T細胞の病原性表型を緩和することが示された.
- 健康なT細胞におけるRUNX2/BHLHE40の過剰発現は,IFN-γ経路と組織在留を高めることを明らかにした.
結論:
- RUNX2とBHLHE40は,クローン病における疾患特有のT細胞形成を駆動する転写プログラムをオーケストラする.
- RUNX2とBHLHE40をターゲットにすることで,CDにおける病原性T細胞の反応を調節する治療戦略を提供することができる.
関連する概念動画
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264
Inflammatory Bowel Disease II: Crohn's Disease
370
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
370
Cells of the Adaptive Immune Response
4.0K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
4.0K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K


